CENTESSA PHARMACEUTICALS PLC CNTA 深 滬
等待開盤 09-20 09:30:00 美东时间
15.85
+0.140
+0.89%
華盛通- 最 高16.79
- 今 開16.49
- 成交量 81.31万股
- 最 低 15.79
- 昨 收 15.71
- 總市值 15.47亿
- 52周最高 17.59
- 市盈率 靜 --
- 換手率 0.83%
- 52周最低 5.15
- 委 比 18.18%
- 總股本 9762.93万
- 歷史最高 26.90
- 量 比 0.57
- 振 幅 6.37%
- 歷史最低 2.885
- 每 手 1
- 風險率 2.33%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多快讯 | Centessa Pharmaceuticals PLC：BMO将目标价从20美元提高至35美元
Centessa Pharmaceuticals PLC : BMO Raises Target Price to $35 From $20
09-16 18:47
Centessa Pharmaceuticals prices $225M equity offfering
Centessa Pharmaceuticals (NASDAQ:CNTA) has priced an upsized underwritten public offering of 15.25M ADS, each representing one ordinary share, at $14.75 per ADS for the aggregate gross proceeds of app...
09-13 12:38
New additions to Roth MKM’s ADR portfolio for September
Roth MKM analysts updated their top ideas within their ADR universe. ADRs are U.S. dollar certificates that trade on American stock exchanges tracking the price of a foreign company’s domestic shares....
09-12 22:41
快讯 | Centessa Pharmaceuticals PLC：Leerink Partners将目标价从14美元上调至22美元
Centessa Pharmaceuticals PLC : Leerink Partners Raises Target Price to $22 From...
09-11 12:09
Relay Therapeutics Faces Downgrade Over Efficacy Concerns in Competitive PI3K Inhibitor Market
Relay Therapeutics shares interim data for RLY-2608 from the ReDiscover study, showing a 57% clinical benefit rate. Oppenheimer downgrades Relay Therapeutics from Outperform to Perform, citing concerns about competitor data and efficacy challenges.
09-11 02:50
Centessa stock jumps 10% on Phase 1 narcolepsy study for ORX750
Shares of Centessa Pharmaceuticals (NASDAQ:CNTA) jumped 10% Tuesday after the company announced positive Phase 1 data for its narcolepsy drug candidate ORX750, with plans to rapidly advance it into Ph...
09-10 23:41
Centessa Shares Rally on Encouraging Narcolepsy-Drug Data
Unity Software(U.US) reported fourth-quarter financial results after the market...
09-10 20:55
Market-Moving News for September 10th
ORCL: 9% | Oracle shares are trading higher following better-than-expected Q1 financial results. JMP Securities upgraded the stock from Market Perform to Market Outperform following the report. VRDN: 16% |
09-10 19:52
美股牛股 | 猴痘药物需求激增！SIGA暴涨26.9%；维多利亚的秘密“换帅”后大涨16%
猴痘药物需求激增！SIGA隔夜股价暴涨26.9%；维多利亚的秘密“换帅”后大涨16%，二季度EPS初步数据超预期>>
08-15 19:32
